期刊文献+

蟾酥中蟾毒配基类成分的分离纯化及其体外抗肿瘤活性的研究 被引量:13

Isolation and antitumor activity in vitro of three kinds of bufadienolides
下载PDF
导出
摘要 目的:研究蟾酥中蟾毒配基类成分的分离纯化方法,并初步考察其体外抗肿瘤活性。方法:采用硅胶柱层析法纯化蟾酥药材粗提物,高效液相法测定三种蟾毒配基含量,以此确定最佳纯化工艺;MTT比色法测定药物对肿瘤细胞的生长抑制作用。结果:用优化工艺制备得到的纯化产物蟾毒配基类成分平均含量为95.98%;纯化产物具有显著的抑制肿瘤细胞生长作用,在0.001~100μg/mL的浓度范围内,药物对人乳腺癌MDA-MB-435细胞和人肺癌A549细胞有很强的抑制作用。结论:硅胶柱层析法适合于蟾酥中蟾毒配基类成分:脂蟾毒配基、华蟾毒基、蟾毒灵的制备,且纯化产物体外抗肿瘤作用显著。 AIM: To isolate three kinds of bufadienolides composition from Venenum bufonis in order to investigate their antitumor activity in vitro.METHODS: Alcohol extraction and isolation by Silica gel colume were employed in this study.Their antitumor activities in vitro were evaluated by MTT colorimetric method.RESULTS: With such methods,three kinds of bufadienolides,including Bufalin,cinobufagin,and resibufogenin with purity above 90% were prepared.The in-vitro results showed that three kinds of bufadienolides had prominent inhibition effect on human lung cancer A549 cells,human breast cancer MDA-MB-435 cells in the range of 0.001 μg/mL ~ 100 μg/mL.CONCLUSION: Isolation by Silica gel colume can be used to separate three kinds of bufadienolides from Venenum bufonis and its constituents has prominent anti-cancer effects.
出处 《中成药》 CAS CSCD 北大核心 2010年第6期937-940,共4页 Chinese Traditional Patent Medicine
基金 上海市科委纳米专项(0652nm013)
关键词 蟾酥 脂蟾毒配基 华蟾毒基和蟾毒灵 分离纯化 抗肿瘤活性 Venenum bufonis bufalin cinobufagin resibufogenin separation and purification antitumor ac- tivity
  • 相关文献

参考文献5

二级参考文献26

共引文献36

同被引文献150

引证文献13

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部